• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph+ lymphoid blast crisis of chronic myeloid leukaemia.

作者信息

Breccia Massimo, Serrao Alessandra, Salaroli Adriano, Loglisci Giuseppina, Zacheo Irene, Alimena Giuliana

出版信息

Br J Haematol. 2012 Dec;159(5):612-3. doi: 10.1111/bjh.12079. Epub 2012 Oct 9.

DOI:10.1111/bjh.12079
PMID:23043319
Abstract
摘要

相似文献

1
Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph+ lymphoid blast crisis of chronic myeloid leukaemia.达沙替尼联合每周一次的长春新碱给药可有效治疗慢性髓性白血病的突发或难治性Ph+淋巴细胞母细胞危象。
Br J Haematol. 2012 Dec;159(5):612-3. doi: 10.1111/bjh.12079. Epub 2012 Oct 9.
2
Sequential mutations causing resistance to both Imatinib Mesylate and Dasatinib in a chronic myeloid leukaemia patient progressing to lymphoid blast crisis.一名慢性髓性白血病进展为淋巴细胞母细胞危象的患者中导致对甲磺酸伊马替尼和达沙替尼均耐药的序贯突变
Leuk Res. 2008 Apr;32(4):673-4. doi: 10.1016/j.leukres.2007.08.008. Epub 2007 Sep 24.
3
Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia.在经历20年“未治疗”的慢性髓性白血病后，化疗和伊马替尼诱导淋巴细胞母细胞危象出现分子缓解。
Am J Hematol. 2007 Apr;82(4):333. doi: 10.1002/ajh.20815.
4
[Dasatinib-related pneumonia? An example of pharmacovigilance survey].
Rev Mal Respir. 2015 Jan;32(1):84-6. doi: 10.1016/j.rmr.2014.08.002. Epub 2014 Sep 26.
5
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.BCR-ABL酪氨酸激酶特异性抑制剂在伴有费城染色体的慢性髓性白血病急变期和急性淋巴细胞白血病中的活性
N Engl J Med. 2001 Apr 5;344(14):1038-42. doi: 10.1056/NEJM200104053441402.
6
Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.伊马替尼对慢性期和急变期慢性髓性白血病患者肿瘤细胞的体外活性。
Anticancer Drugs. 2006 Jul;17(6):631-9. doi: 10.1097/01.cad.0000217423.59831.db.
7
High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia.大剂量甲磺酸伊马替尼联合长春新碱和地塞米松（DIV方案）作为难治性费城染色体阳性急性淋巴细胞白血病和慢性粒细胞白血病淋巴母细胞危象患者的诱导治疗。
Leukemia. 2006 Mar;20(3):400-3. doi: 10.1038/sj.leu.2404115.
8
A case of acute colitis with severe rectal bleeding in a patient with chronic myeloid leukemia after dasatinib use.
Acta Haematol. 2010;123(4):205-6. doi: 10.1159/000306070. Epub 2010 Apr 8.
9
Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias.达沙替尼用于伊马替尼耐药的费城染色体阳性白血病。
N Engl J Med. 2006 Jun 15;354(24):2531-41. doi: 10.1056/NEJMoa055229.
10
Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformation.达沙替尼与FLAG-IDA联合治疗慢性粒细胞白血病急变期患者的疗效
Haematologica. 2012 Mar;97(3):473-4. doi: 10.3324/haematol.2011.057513. Epub 2011 Dec 1.

引用本文的文献

1
[The progress in classification and prognosis evaluation of BCR::ABL1 positive acute lymphoblastic leukemia].[BCR::ABL1 阳性急性淋巴细胞白血病的分类及预后评估进展]
Zhonghua Xue Ye Xue Za Zhi. 2024 Jul 14;45(7):705-710. doi: 10.3760/cma.j.cn121090-20240315-00096.
2
Understanding and Monitoring Chronic Myeloid Leukemia Blast Crisis: How to Better Manage Patients.理解与监测慢性髓性白血病急变期：如何更好地管理患者
Cancer Manag Res. 2021 Jun 23;13:4987-5000. doi: 10.2147/CMAR.S314343. eCollection 2021.
3
Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells.
达沙替尼与吉西他滨联合使用可降低ALDH1A1的表达，并抑制吉西他滨耐药的胰腺癌MIA PaCa-2细胞的增殖。
Int J Oncol. 2014 Jun;44(6):2132-8. doi: 10.3892/ijo.2014.2357. Epub 2014 Mar 21.